Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

Share Price is delayed by 15 minutes
Get Live Data
33.40    1.20 (3.73%)
Bid:
31.60
Ask:
32.80
Spread: 1.20 (3.797%)
Market Cap: £91.40m
GMR Live PriceLast checked at - London Stock Exchange

Intraday Gaming Realms Share Chart

AGM Statement

28 Feb 2011 07:00

RNS Number : 9316B
Pursuit Dynamics PLC
28 February 2011
 



28 February 2011

Pursuit Dynamics PLC (AIM: PDX)

("PDX" or the "Company')

 

AGM Statement

 

PDX will be holding its Annual General Meeting today at 12:00 a.m. (noon). In his address to shareholders, Chairman, Mr. Andrew Quinn will provide the following update:

 

Introduction

 

"Since our last AGM, PDX has had a busy year and has made tremendous progress on a wide range of fronts. The management reorganisation that we highlighted last year has led to the appointment of new leaders for our Biofuels and Brewing, Food and Beverages businesses, each of whom are leaders in their field. Each Line of Business ("LOB") has established an impressive pipeline of target contracts that are now at various stages of commercial development.

 

We have also broadened significantly our coverage of patent protection as our business opportunities have been expanded. We have also continued to recruit high quality scientists, project managers and business development professionals to augment our current capability.

 

A key joint venture has been established with National Nuclear Laboratory Ltd to exploit our de-contamination capability in the civil nuclear industry. New relationships have been established with major partners, such as Proctor and Gamble and Kärcher Futuretech GmbH ("Kärcher").

 

In May 2010 we successfully raised additional funds for the business under the leadership of our CEO, Roel Pieper, which put us on a sound financial footing.

 

We have appointed a new CFO, Richard Webster, to strengthen our management team, and have reviewed our corporate structure to improve its tax-efficiency.

 

Biofuels

 

In October last year a milestone decision was made by US Government to increase the amount of ethanol mixed with gasoline (the "blendwall") by 50%. This change has created a significant opportunity for PDX in that our technology allows our customers to increase output volumes from existing production assets at very modest cost and with little or no disruption. Excellent progress has been made in a number of well-executed installations at plants, proving we now have the skills to deliver our technology on our clients' sites, no matter how geographically remote. At the Pacific Ethanol Inc. plant in Boardman, Oregon, we are in the final legal stages of agreeing the revenue contract following successful implementation, securing our first biofuels revenue in Q1 of this calendar year. We have completed the installation of a larger system at the MABE plant in Madrid, Nebraska which is currently commencing operational validation and base-lining. The Marquis Energy plant near Hennepin, Illinois, will complete installation in early March and commence operational validation immediately thereafter. There has been an inevitable learning process in this business and we are already seeing an acceleration in the time to complete on-site installation. A further four plants have entered agreements to install the ERS (Ethanol Reactor System), which will be installed this financial year. Altogether the current combined capacity of these seven plants is 480 million gallons per year.

 

Brewing, Food and Beverages

 

Major progress has been made in the Brewing sector. In September we announced an agreement with Oettinger Brauerei GmbH, one of the major food and beverage companies in Germany, which is renowned as an efficient low-cost producer, to install a new PDX brewing system at one of its many plants. We have signed a small deal with a brewer in the USA which aims to be one of the most eco-friendly brewers in the USA, giving us, for the first time, a reference site in the important US market. Negotiations are in place with two of the world's four largest brewers, at one of which, MillerCoors, we now have a pilot project agreed. In Germany we have agreed to trials with a further two of the five largest German brewers. We also secured the prestigious Reinheitsgebot accreditation proving our technology's compliance with the very strict German beer purity regulations. These are a benchmark for many other countries.

In the food sector we have re-invigorated our sales capability, and now are building up a very satisfactory pipeline focussed on clients with European and US operations, for both retro fit and new plant installations.

 

Industrial Licensing

 

Our relationship with Tyco has been established for some time, and, following receipt of Factory Mutual approvals and a the launch of its Aquasonic fire suppression product range last year, we see a growing pipeline of orders and anticipate the receipt of modest revenues this financial year, despite the difficult capital goods market conditions in which Tyco is operating.

 

On November 5th, 2010 PDX announced a Joint Development Agreement ("JDA") with P&G that enables P&G to develop specific applications using the PDX reactor technology in a wide range of its production processes. The JDA is the culmination of trials that commenced in the spring of 2010. The new agreement will enable P&G's technical centres to embed the PDX technology inside their global facilities. This will enable them to assess the potential cost and energy savings of using PDX's technology in its manufacturing processes.

 

Kärcher and PDX announced in April a partnership agreement to form a 50/50 joint venture to jointly develop, produce and market products in the Public Health and Decontamination sector. As a result, PDX and Kärcher have started joint research and development across five product lines and expect to deliver the first joint products in late summer this year.

 

Water

 

The new Water LOB was established in December 2010 in response to the interest in the potential of the PDX technology in a variety of applications, including waste water treatment, desalination and cleaning marine shipping ballast water. Encouraging trials at a waste water treatment plant in Albertville, Alabama, USA, during 2010 led us to believe that there is a very significant opportunity for PDX to apply its core technology in this major sector on a global basis.

 

Public Health and Decontamination

 

In February 2011 we announced the creation of a NDX Solutions Ltd ("NDX"), in which PDX has a 60% stake, a joint venture with National Nuclear Laboratories Ltd, to develop, produce and market products for the global nuclear market. Revenues from the joint venture commenced in the first quarter of the current of calendar year and are expected to build quarter over quarter as technology applications are rolled out.

 

Conclusion

 

PDX has demonstrated considerable progress over the past year, under the capable leadership of our CEO Roel Pieper. He has created a high performing team capable of delivering world class value. 2011 is a pivotal year for the Company as we start to see new revenue streams coming on line. Much speculation has been made about the ability of the business to deliver to customer expectations, but the Company is very confident that the technology, the team and the strategy are in place that can deliver genuinely valuable solutions to PDX's clients and strong returns for shareholders."

 

 

- Ends -

 

 

For Further Information, please contact:

 

PDX

Roel Pieper, CEO

Tel: +44 (0)1480 422050

Richard Webster, CFO

Financial Dynamics

Ben Foster

Marc Cohen

Tel: +44 (0) 20 7831 3113

 

 

 

Cenkos Securities

Ian Soanes

Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities

Rory Scott

Tel: +44 (0) 20 7878 3360

 

 

Notes to Editors

 

About PDX

 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

 

- The PDX business model is currently organised into five Lines of Business - Biofuels; Brewing, Food and Beverages; Public Health and Decontamination; Industrial Licensing; Water.

 

- PDX is headquartered in Huntingdon (UK) with an office in London (UK), Schaffhausen (Switzerland) and Connecticut (USA).

 

- Further information is available at the Company's website: www.pdx.biz 

 

- Publication quality photographs are available from FD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSEDEFWFFSESE
Date   Source Headline
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:02 amRNSShare Buyback Programme
31st Mar 20257:00 amRNSAnnual Results 2024
28th Feb 202512:05 pmRNSTotal Voting Rights and Share Capital
4th Feb 20257:00 amRNSFY24 Pre-Close Trading Update
29th Jan 20253:45 pmRNSBlock Listing Six Monthly Return
22nd Jan 20253:20 pmRNSHolding(s) in Company
11th Sep 20247:00 amRNSInterim Results
7th Aug 20243:00 pmRNSAdoption and grant of options
2nd Aug 20245:00 pmRNSShare Capital Reduction
30th Jul 20247:00 amRNSPre-Close Trading Update
29th Jul 20248:00 amRNSBlock Listing Six Monthly Return
27th Jun 20242:20 pmRNSTotal Voting Rights and Share Capital
14th Jun 20249:57 amRNSResult of AGM
2nd Apr 20247:01 amRNSInvestor Presentation
2nd Apr 20247:00 amRNSAnnual Results 2023
27th Mar 20244:05 pmRNSTotal Voting Rights and Share Capital
5th Feb 20247:00 amRNSPre-Close Trading Update
30th Jan 20244:00 pmRNSTotal Voting Rights and Share Capital
30th Jan 20244:00 pmRNSBlock Listing Six Monthly Return
30th Nov 20237:00 amRNSTotal Voting Rights and Share Capital
28th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20234:59 pmRNSDirector/PDMR Shareholding
28th Jul 20232:00 pmRNSTotal Voting Rights and Share Capital
28th Jul 20232:00 pmRNSBlock Listing Six Monthly Return
27th Jul 20237:00 amRNSPre-Close Trading Update
30th Jun 20233:02 pmRNSTotal Voting Rights and Share Capital
31st May 202312:35 pmRNSResult of AGM
3rd Apr 20237:00 amRNSAnnual Results 2022
1st Feb 20237:00 amRNSPre-Close Trading Update and Board Changes
30th Jan 20231:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20237:00 amRNSGaming Realms to Introduce Tetris® Slingo®
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSAppointment of Joint Broker
12th Dec 20227:00 amRNSRepayment of Loan
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSBoard Appointment
25th Oct 20227:00 amRNSGaming Realms launches content in Connecticut
14th Oct 20224:40 pmRNSSecond Price Monitoring Extn
14th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSRetail Investor Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.